©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 111808
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.111808
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.111808
Table 3 Correlation of serum homocysteine, uric acid, and best-corrected visual acuity, superficial capillary plexus within the proliferative diabetic retinopathy group (n = 44)
| Variables | Time | Serum Hcy (μmol/L) | Serum UA (μmol/L) | ||
| Pearson | P value | Pearson | P value | ||
| BCVA (logMAR) | 7 days | -0.029 | 0.866 | -0.079 | 0.643 |
| 30 days | -0.150 | 0.474 | 0.068 | 0.749 | |
| 90 days | -0.046 | 0.877 | 0.040 | 0.893 | |
| SCP vessel length density (mm) | 7 days | -0.214 | 0.063 | -0.056 | 0.632 |
| 30 days | -0.116 | 0.332 | -0.154 | 0.196 | |
| 90 days | -0.183 | 0.115 | -0.172 | 0.141 | |
| SCP vessel width density (mm2) | 7 days | -0.223 | 0.053 | -0.009 | 0.936 |
| 30 days | -0.042 | 0.724 | -0.053 | 0.656 | |
| 90 days | -0.126 | 0.282 | -0.170 | 0.144 | |
- Citation: Ran QB, Lei CY, Gao S, Yang XG, Jiang FP, Zhang MX. Association of serum and vitreous homocysteine and uric acid concentrations with post-vitrectomy prognosis in patients with proliferative diabetic retinopathy. World J Diabetes 2026; 17(1): 111808
- URL: https://www.wjgnet.com/1948-9358/full/v17/i1/111808.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i1.111808